BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9669874)

  • 1. Two more HIV protease inhibitors approved.
    Fox JL
    Nat Biotechnol; 1996 Apr; 14(4):427. PubMed ID: 9669874
    [No Abstract]   [Full Text] [Related]  

  • 2. Viramune cleared for use in combination with protease inhibitors.
    AIDS Patient Care STDS; 1998 Nov; 12(11):872. PubMed ID: 11362046
    [No Abstract]   [Full Text] [Related]  

  • 3. AmFAR extols FDA on rapid approval of two protease inhibitors.
    AIDS Patient Care STDS; 1996 Jun; 10(3):193-4. PubMed ID: 11361645
    [No Abstract]   [Full Text] [Related]  

  • 4. New drugs--reports of new drugs recently approved by the FDA. Indinavir.
    Bioorg Med Chem; 1997 Mar; 5(3):463-4. PubMed ID: 9113322
    [No Abstract]   [Full Text] [Related]  

  • 5. New drugs--reports of new drugs recently approved by the FDA. Ritonavir.
    Bioorg Med Chem; 1997 Mar; 5(3):461-2. PubMed ID: 9113321
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA approves 2 new protease inhibitors: ritonavir (Norvir) and Crixivan (Indinavir sulfate). Food and Drug Administration.
    Schouten JT
    STEP Perspect; 1996; 8(1):7-8. PubMed ID: 11363592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ritonavir and indinavir one year later.
    TreatmentUpdate; 2001; 12(12):6-7. PubMed ID: 11570094
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV drug now approved for use with protease inhibitors.
    Nurse Pract; 1998 Oct; 23(10):89. PubMed ID: 9805335
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of indinavir and ritonavir on warfarin anticoagulant activity.
    Gatti G; Alessandrini A; Camera M; Di Biagio A; Bassetti M; Rizzo F
    AIDS; 1998 May; 12(7):825-6. PubMed ID: 9619821
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors for ritonavir intolerance and outcome after change to indinavir.
    Casado JL; Perez-Elías MJ; Antela A; Martí-Belda P; de Lucas S; Muñoz V; Guerrero A
    AIDS; 1998 Feb; 12(3):335-6. PubMed ID: 9580044
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiretroviral approved for use in infants.
    Am Fam Physician; 2001 Jun; 63(12):2469. PubMed ID: 11430459
    [No Abstract]   [Full Text] [Related]  

  • 12. [HIV protease inhibitors].
    Rubio R; Romeu J; Viciana P; Redondo C
    Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():10-4. PubMed ID: 9053020
    [No Abstract]   [Full Text] [Related]  

  • 13. FDA rapidly approves HIV protease inhibitors for children.
    Fox JL
    Nat Biotechnol; 1997 May; 15(5):404. PubMed ID: 9131607
    [No Abstract]   [Full Text] [Related]  

  • 14. Using ritonavir with indinavir in cases of virologic failure.
    TreatmentUpdate; 2001; 12(12):7. PubMed ID: 11570095
    [No Abstract]   [Full Text] [Related]  

  • 15. Lower dose of ritonavir approved for use with fosamprenavir.
    Sax PE
    AIDS Clin Care; 2007 Dec; 19(12):106. PubMed ID: 18399004
    [No Abstract]   [Full Text] [Related]  

  • 16. Indinavir approved for HIV infection.
    Am Fam Physician; 1996 May; 53(6):2203. PubMed ID: 8623727
    [No Abstract]   [Full Text] [Related]  

  • 17. What they say about protease inhibitors.
    Posit Aware; 1999; 10(1):38-43. PubMed ID: 11366522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective follow-up of 67 indinavir-experienced human immunodeficiency virus-infected and AIDS patients treated with the ritonavir/saquinavir combination.
    Lallemand F; Adda N; Schneider V; Jacomet C; Salhi Y; Rozenbaum W
    Clin Infect Dis; 1999 May; 28(5):1184-5. PubMed ID: 10452672
    [No Abstract]   [Full Text] [Related]  

  • 19. Antiretroviral therapy and clinical trials: what now?
    Lange JM; Richman DD
    Antivir Ther; 1996 Apr; 1(2):69-70. PubMed ID: 11321181
    [No Abstract]   [Full Text] [Related]  

  • 20. Pediatric treatments.
    AIDS Policy Law; 1997 Apr; 12(6):12. PubMed ID: 11364179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.